Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Oct 9;22(10):e17435.
doi: 10.2196/17435.

Effect of Smartphone-Based Lifestyle Coaching App on Community-Dwelling Population With Moderate Metabolic Abnormalities: Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Effect of Smartphone-Based Lifestyle Coaching App on Community-Dwelling Population With Moderate Metabolic Abnormalities: Randomized Controlled Trial

So Mi Jemma Cho et al. J Med Internet Res. .

Abstract

Background: Metabolic disorders are established precursors to cardiovascular diseases, yet they can be readily prevented with sustained lifestyle modifications.

Objective: We assessed the effectiveness of a smartphone-based weight management app on metabolic parameters in adults at high-risk, yet without physician diagnosis nor pharmacological treatment for metabolic syndrome, in a community setting.

Methods: In this 3-arm parallel-group, single-blind, randomized controlled trial, we recruited participants aged 30 to 59 years with at least 2 conditions defined by the Third Report of the National Cholesterol Education Program expert panel (abdominal obesity, high blood pressure, high triglycerides, low high-density lipoprotein cholesterol, and high fasting glucose level). Participants were randomly assigned (1:1:1) by block randomization to either the nonuser group (control), the app-based diet and exercise self-logging group (app only), or the app-based self-logging and personalized coaching from professional dieticians and exercise coordinators group (app with personalized coaching). Assessments were performed at baseline, week 6, week 12, and week 24. The primary outcome was change in systolic blood pressure (between baseline and follow-up assessments). Secondary outcomes were changes in diastolic blood pressure, body weight, body fat mass, waist circumference, homeostatic model of assessment of insulin resistance, triglyceride level, and high-density lipoprotein cholesterol level between baseline and follow-up assessments. Analysis was performed using intention-to-treat.

Results: Between October 28, 2017 and May 28, 2018, 160 participants participated in the baseline screening examination. Participants (129/160, 80.6%) who satisfied the eligibility criteria were assigned to control (n=41), app only (n=45), or app with personalized coaching (n=43) group. In each group, systolic blood pressure showed decreasing trends from baseline (control: mean -10.95, SD 2.09 mmHg; app only: mean -7.29, SD 1.83 mmHg; app with personalized coaching: mean -7.19, SD 1.66 mmHg), yet without significant difference among the groups (app only: P=.19; app with personalized coaching: P=.16). Instead, those in the app with personalized coaching group had greater body weight reductions (control: mean -0.12, SD 0.30 kg; app only: mean -0.35, SD 0.36 kg, P=.67; app with personalized coaching: mean -0.96, SD 0.37 kg; P=.08), specifically by body fat mass reduction (control: mean -0.13, SD 0.34 kg; app only: mean -0.64, SD 0.38 kg, P=.22; app with personalized coaching: mean -0.79, SD 0.38 kg; P=.08).

Conclusions: Simultaneous diet and exercise self-logging and persistent lifestyle modification coaching were ineffective in lowering systolic blood pressure but effective in losing weight and reducing body fat mass. These results warrant future implementation studies of similar models of care on a broader scale in the context of primary prevention.

Trial registration: ClinicalTrials.gov NCT03300271; http://clinicaltrials.gov/ct2/show/NCT03300271.

Keywords: health behavior; lifestyle modification; metabolic health; mobile health.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Flow diagram of the study participants. CMERC: Cardiovascular and Metabolic Diseases Etiology Research Center.
Figure 2
Figure 2
Example of personalized coaching.
Figure 3
Figure 3
Systolic blood pressure changes from the baseline across the 3 groups at each time point. AO: app-only; APC: app with personalized coaching; CO: control, SBP: systolic blood pressure.
Figure 4
Figure 4
Body weight changes from the baseline across the 3 groups at each time point. AO: app-only; APC: app with personalized coaching; CO: control, SBP: systolic blood pressure.
Figure 5
Figure 5
Body fat mass changes from the baseline across the 3 groups at each time point. AO: app-only; APC: app with personalized coaching; CO: control.

Similar articles

Cited by

References

    1. Wilson PWF, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005 Nov 15;112(20):3066–72. doi: 10.1161/CIRCULATIONAHA.105.539528. http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=16275870 - DOI - PubMed
    1. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The Metabolic Syndrome and Cardiovascular Risk. Journal of the American College of Cardiology. 2010 Sep;56(14):1113–1132. doi: 10.1016/j.jacc.2010.05.034. - DOI - PubMed
    1. Kang S, Kim S, Cho JH, Yoon C, Hwang S, Lee H, Youn T, Chae I, Kim C. Prevalence, Awareness, Treatment, and Control of Hypertension in Korea. Sci Rep. 2019 Jul 29;9(1):10970. doi: 10.1038/s41598-019-46965-4. doi: 10.1038/s41598-019-46965-4. - DOI - DOI - PMC - PubMed
    1. Kim B, Won JC, Lee JH, Kim H, Park JH, Ha KH, Won KC, Kim DJ, Park KS. Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status. Diabetes Metab J. 2019;43(4):487. doi: 10.4093/dmj.2019.0067. - DOI - PMC - PubMed
    1. Jeong JS, Kwon HS. Prevalence and Clinical Characteristics of Dyslipidemia in Koreans. Endocrinol Metab (Seoul) 2017 Mar;32(1):30–35. doi: 10.3803/EnM.2017.32.1.30. https://e-enm.org/DOIx.php?id=10.3803/EnM.2017.32.1.30 - DOI - PMC - PubMed

Publication types

Associated data